|
⚲
|
| Keyboard |
| Richard Markham | |
|---|---|
| Firm | |
| Address | c/o Nephrogenex, Inc 3200 Beechleaf Court, Suite 900 Raleigh, NC 27604 |
| Source |
| Associated Funds | Form D | Role | 2011 - 2026 | Raised | AUM |
|---|---|---|---|---|---|
| Nephrogenex Inc | 021-251166 | Director | 5.5 M of 28.5 M |
||
| Colucid Pharmaceuticals Inc | 021-232838 | Director | 37.1 M of 37.1 M |
||
| Vaxart Inc | 021-200797 | Director | 20.0 M of 20.0 M |
||
| Anacor Pharmaceuticals Inc | 021-157667 | Director | of 1.6 M |
||
| Colucid Pharmaceuticals Inc | 021-156147 | Director | 8.2 M of 9.5 M |
||
| Anacor Pharmaceuticals Inc | 021-151359 | Director | 10.0 M of 10.0 M |
||
| Nephrogenex Inc | 021-145311 | Director | 1.0 M of 1.0 M |
||
| Colucid Pharmaceuticals Inc | 021-84673 | Director | 9.2 M of 13.8 M |
||
| Vaxart Inc | 021-137854 | Director | 16.9 M of 16.9 M |
||